Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The study was designed to examine the efficacy and tolerability of quetiapine XR for the
treatment of women who suffer from depression in the context of the menopausal transition and
postmenopausal years. Besides the improvement of depressive symptoms, the investigators are
interested in examining the impact of this medication on vasomotor symptoms (hot flashes,
night sweats), sleep and overall quality of life.